Dallas, TX, United States of America

Tong-Jin Zhao

This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2011-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tong-Jin Zhao. Retrieved from https://idiyas.com/inventor/tong-jin-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Tong-Jin Zhao

Introduction

Tong-Jin Zhao is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of biochemistry, particularly in the development of small molecule inhibitors. With a total of 2 patents, Zhao's work has the potential to impact various therapeutic areas.

Latest Patents

Zhao's latest patents focus on small molecule inhibitors of ghrelin O-acyltransferase (GOAT). These inhibitors are designed to interact with GOAT, leading to a resultant inhibition that could have implications for metabolic disorders. The methods described in his patents involve contacting GOAT with an inhibitor and detecting the resultant inhibition, showcasing innovative approaches to tackling health issues.

Career Highlights

Zhao is affiliated with the University of Texas System, where he continues to advance his research. His work is characterized by a commitment to exploring new therapeutic avenues and enhancing our understanding of metabolic processes.

Collaborations

Some of his notable coworkers include Patrick G. Harran and Michael S. Brown. Their collaborative efforts contribute to the innovative research environment at the University of Texas System.

Conclusion

Tong-Jin Zhao's contributions to the field of biochemistry through his patents on small molecule inhibitors highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future therapeutic developments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…